NCT02422394View on ClinicalTrials.gov

Eltrombopag for Inherited Thrombocytopenias

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions
Inherited Platelet Disorder
Interventions
DRUG

Eltrombopag

Trial Locations (3)

27100

Unit of Internal Medicine 3, IRCCS Policlinico San Matteo Foundation, Pavia

35128

Department of Internal Medicine, Hospital of Padova, Padua

06126

Section of Internal and Cardiovascular Medicine, Department of Medicine, University Hospital of Perugia, Perugia

All Listed Sponsors
lead

Fondazione IRCCS Policlinico San Matteo di Pavia

OTHER

NCT02422394 - Eltrombopag for Inherited Thrombocytopenias | Biotech Hunter | Biotech Hunter